IA
CGON icon

IFP Advisors’s CG Oncology CGON Stock Holding History

IFP Advisors’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$497 Hold
7
– – ﹤0.01% 4685
2026
Q1 		$474 Hold
7
– – ﹤0.01% 4432
2025
Q4 		$291 Hold
7
– – ﹤0.01% 4412
2025
Q3 		$282 Buy
+7
New +$204 ﹤0.01% 4317
2025
Q2 		– Hold
0
– – – 3616
2025
Q1 		– Sell
-1
Closed -$29 – 4373
2024
Q4 		$29 Buy
+1
New +$34 ﹤0.01% 4382

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IFP Advisors's CGON Position: Q2 2026 in Review

IFP Advisors held its CG Oncology (CGON) position steady in Q2 2026 at 7 shares worth $497. The position accounts for ﹤0.01% of the portfolio, ranked #4685.

IFP Advisors first reported a position in CGON in Q4 2024 and has held it in 5 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • IFP Advisors held 7 shares of CG Oncology worth $497 as of Q2 2026.
  • IFP Advisors left its CG Oncology share count unchanged in Q2 2026.
  • CG Oncology made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4685 holding.
  • IFP Advisors first reported a position in CG Oncology in Q4 2024 and has held it in 5 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.